U.S., July 12 -- ClinicalTrials.gov registry received information related to the study (NCT07061184) titled 'Fengliao Changweikang for Diarrhea-predominant Irritable Bowel Syndrome: N-of-1 Trial' on July 02.
Brief Summary: Irritable bowel syndrome with diarrhea (IBS-D) is a functional gastrointestinal disorder, with characteristics of defecation related abdominal pain and diarrhea. Routine treatment strategy for IBS-D is symptom-based with unsatisfactory results, while there is a growing interest in complementary and alternative medicine such as Traditional Chinese Medicine. However, lack of high-quality evidences being the obstacle for its development.
This study aims to evaluate the efficacy of Fengliao Changweikang Keli (FLCWK) on symp...